Avantor Inc. (AVTR)
16.61
0.33 (2.03%)
At close: Mar 21, 2025, 3:59 PM
16.44
-1.07%
After-hours: Mar 21, 2025, 06:20 PM EDT
2.03% (1D)
Bid | 16.15 |
Market Cap | 11.31B |
Revenue (ttm) | 6.79B |
Net Income (ttm) | 712.13M |
EPS (ttm) | 1.04 |
PE Ratio (ttm) | 15.98 |
Forward PE | 20.33 |
Analyst | Buy |
Ask | 16.61 |
Volume | 6,895,928 |
Avg. Volume (20D) | 7,302,190.5 |
Open | 16.15 |
Previous Close | 16.28 |
Day's Range | 16.09 - 16.62 |
52-Week Range | 15.37 - 28.00 |
Beta | 1.30 |
About AVTR
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography r...
Industry Chemicals - Specialty
Sector Basic Materials
IPO Date May 17, 2019
Employees 13,500
Stock Exchange NYSE
Ticker Symbol AVTR
Website https://www.avantorsciences.com
Analyst Forecast
According to 12 analyst ratings, the average rating for AVTR stock is "Buy." The 12-month stock price forecast is $25, which is an increase of 50.47% from the latest price.
Stock ForecastsNext Earnings Release
Avantor Inc. is scheduled to release its earnings on Apr 25, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-3.26%
Avantor shares are trading lower after multiple fi...
Unlock content with
Pro Subscription
1 month ago
-11.71%
Avantor shares are trading lower after the company reported Q4 financial results and missed its adjusted EPS estimate.